Glenmede Trust’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Glenmede Trust’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-24	Closed	-$2K	–	2849
2015 Q1	$2K	Sell	24 -9	-27%	-$858	﹤0.01%	2377
2014 Q4	$3K	Buy	+33	New	+$3.15K	﹤0.01%	2394

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Glenmede Trust's PTX Position: Q2 2015 in Review

Glenmede Trust sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2015, closing a stake of 24 shares — an estimated $2K sold.

Glenmede Trust first reported a position in PTX in Q4 2014 and held it in 2 quarters. The position peaked at $3K in Q4 2014. 114 funds tracked by Wall St. Rank hold PTX as of Q2 2015.

Glenmede Trust reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
Glenmede Trust sold 24 Pernix Therapeutics Holdings, Inc. shares in Q2 2015, an estimated $2K.
Glenmede Trust first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2014 and held it in 2 quarters.
Glenmede Trust's Pernix Therapeutics Holdings, Inc. position peaked at $3K in Q4 2014.
114 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2015.

Based on Glenmede Trust's 13F filing for Q2 2015, filed 22 Jul 2015.